Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Lingua: | |
| Pubblicazione: |
Zenodo
2025
|
| Soggetti: | |
| Accesso online: | https://doi.org/10.5281/zenodo.17607448 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Sommario:
- <div dir="ltr"> <p>This report forecasts the Global Beta-lactam and Beta-lactamase Inhibitors Market to grow to $34.20 billion by 2030 (1.9% CAGR), driven by the widespread incidence of infectious diseases and the continuous development of novel combination therapies. The market is defined by the critical need to overcome antibiotic resistance across various indications like respiratory, skin, and urinary tract infections. To access the full report, visit - <a href="https://www.nextmsc.com/report/beta-lactam-beta-lactamase-inhibitors-market">https://www.nextmsc.com/report/beta-lactam-beta-lactamase-inhibitors-market</a></p> </div> <p></p>